Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | BRD4 | O60885 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.55 |
| ▸ | CCR2 | P41597 | 13/20 | 0.48 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2780532 | 0.99 | HSD11B1 (0.55) | HSD11B1KDM4EBRD4ALDH1A1POLB | |
| SCHEMBL2782836 | 0.95 | HSD11B1 (0.61) | HSD11B1KDM4EBRD4ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL2784606 | 0.94 | HSD11B1 (0.60) | HSD11B1KDM4EBRD4ALDH1A1POLB | |
| SCHEMBL2784514 | 0.90 | HSD11B1 (0.55) | HSD11B1KDM4EBRD4ALDH1A1POLB | |
| SCHEMBL2781247 | 0.90 | OPRM1 (0.48) | HSD11B1KDM4EBRD4ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL2782823 | 0.89 | HSD11B1 (0.55) | HSD11B1KDM4EBRD4ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL2781074 | 0.89 | OPRM1 (0.48) | HSD11B1KDM4EBRD4ALDH1A1POLB | |
| SCHEMBL2779499 | 0.88 | HSD11B1 (0.53) | HSD11B1KDM4EBRD4ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL2779810 | 0.87 | HSD11B1 (0.52) | HSD11B1KDM4EBRD4ALDH1A1POLB | |
| SCHEMBL2785350 | 0.80 | HSD11B1 (0.56) | HSD11B1KDM4EBRD4ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1560823-B1 | 4-SUBSTITUTED 1-AMINOCYCLOHEXANE DERIVATIVES FOR UTILIZATION AS ORL1-RECEPTOR AND MU-OPIATE RECEPTOR LIGANDS | GRUENENTHAL GMBH (DE) | 2008-07-09 | — | — | EP | claimed |
| US-20050277674-A1 | 4-substituted 1-aminocyclohexane compounds for utilization as ORL1-receptor and mu-opiate receptor ligands | GRUENENTHAL GMBH (DE) | 2005-12-15 | — | — | US | claimed |
| US-7759385-B2 | 4-substituted 1-aminocyclohexane compounds for utilization as ORL1-receptor and mu-opiate receptor ligands | GRUENENTHAL GMBH (DE) | 2010-07-20 | — | — | US | disclosed |
| EP-1560823-B1 | 4-SUBSTITUTED 1-AMINOCYCLOHEXANE DERIVATIVES FOR UTILIZATION AS ORL1-RECEPTOR AND MU-OPIATE RECEPTOR LIGANDS | GRUENENTHAL GMBH (DE) | 2008-07-09 | — | — | EP | disclosed |
| US-20050277674-A1 | 4-substituted 1-aminocyclohexane compounds for utilization as ORL1-receptor and mu-opiate receptor ligands | GRUENENTHAL GMBH (DE) | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277674-A1 | 4-substituted 1-aminocyclohexane compounds for utilization as ORL1-receptor and mu-opiate receptor ligands | OPRL1, OPRM1, OGFRL1 | HSD11B1 1807/4885KDM4E 3884/4885BRD4 3040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.